Previous 10 | Next 10 |
home / stock / myco:cc / myco:cc news
DENVER, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) ("Mydecine" or the "Company"), a biotechnology company aiming to transform the treatment of mental health and addiction disorders, today reported company highlights and financial result...
Mydecine (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) , is a biotechnology company engineering the next wave of innovative medications and treatment protocols to directly address mental health with a particular emphasis on addiction and PTSD. The company today announced that, in connection with its...
MYDECINE INNOVATIONS GROUP ANNOUNCES CLOSING UNDER SHARE SUBSCRIPTION AGREEMENT AND WELCOMES NEW CFO Canada NewsWire DENVER , Sept. 23, 2022 /CNW/ - Mydecine Innovations Group Inc. ("Mydecine" or the "Company") (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) ...
MYDECINE INNOVATIONS GROUP FILES PROSPECTUS SUPPLEMENT AND ANNOUNCES CLOSING UNDER SHARE SUBSCRIPTION AGREEMENT Canada NewsWire DENVER , Sept. 14, 2022 /CNW/ - Mydecine Innovations Group Inc. ("Mydecine" or the "Company") (NEO: MYCO) (OTC: MYCOF) (FSE...
DENVER, Sept. 01, 2022 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. ("Mydecine" or the "Company") (NEO:MYCO) (OTC:MYCOF) (FSE:0NFA), a biotechnology company engineering the next wave of innovative medications and treatment protocols to directly address mental health with a particular...
Mydecine Innovations (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) , a biotechnology company engineering the next wave of innovative medications and treatment protocols to directly address mental health with a particular emphasis on addiction and post-traumatic stress disorder, has entered into...
DENVER, Aug. 19, 2022 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. (“Mydecine” or the “Company”) (NEO:MYCO) (OTC:MYCOF) (FSE:0NFA), a biotechnology company engineering the next wave of innovative medications and treatment protocols to directly addr...
DENVER, Aug. 15, 2022 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) ("Mydecine" or the "Company"), a biotechnology company aiming to transform the treatment of mental health and addiction disorders, today reported financial results for the six months en...
MYDECINE INNOVATIONS GROUP ANNOUNCES RESIGNATION OF DIRECTORS Canada NewsWire DENVER , Aug. 12, 2022 /CNW/ - Mydecine Innovations Group Inc. ("Mydecine" or the "Company") (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA), a biotechnology company engineering the ne...
Mydecine Innovations (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) , a biotechnology company aiming to transform the treatment of mental health and addiction disorders, has successfully synthesized multiple short-acting MDMA analogs and has filed a patent covering these novel molecules. Experts...
News, Short Squeeze, Breakout and More Instantly...
MYDECINE INNOVATIONS GROUP INC. Company Name:
MYCO:CC Stock Symbol:
AQNC Market:
MYDECINE INNOVATIONS GROUP INC. Website:
A look at the top 10 most actives in Canada Canadian Natural Resources Limited (CNQ) rose 1.6% to $49.86 on volume of 16,918,783 shares Cenovus Energy Inc. (CVE) rose 1.2% to $27.09 on volume of 11,032,869 shares Toronto-Dominion Bank (The) (TD) rose 1.0% to $76.74 on volume of 10,871,605...
A look at the top 10 most actives in Canada Toronto-Dominion Bank (The) (TD) rose 0.3% to $76.13 on volume of 16,847,005 shares Canadian Natural Resources Limited (CNQ) fell 1.5% to $48.33 on volume of 7,922,140 shares TC Energy Corporation (TRP) rose 0.1% to $51.11 on volume of 7,293,869...
(TheNewswire) Vancouver, British Columbia, July 5, 2024— TheNewswire – Mydecine Innovations Group Inc. (the “ Company ”) (CSE: MYCO) (FSE: 0NF0) (OTC: MYCOF) (AQSE: MYIG) is pleased to confirm that further to its news release dated June 13, 2024, ...